In a small study, researchers have found that an Ozempic-style drug seems to slow the progression of Alzheimer's, adding to the growing list of off-label applications for this groundbreaking class of medications. Presented this week at the Alzheimer's Association International Conference, this small study out of Imperial College London study focused on 204 Alzheimer's patients […]